A fertility-sparing alternative to radical hysterectomy: how many patients may be eligible?

被引:116
作者
Sonoda, Y [1 ]
Abu-Rustum, NR [1 ]
Gemignani, ML [1 ]
Chi, DS [1 ]
Brown, CL [1 ]
Poynor, EA [1 ]
Barakat, RR [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, GYN Serv Acad Off, Gynecol Serv, Dept Surg, New York, NY 10021 USA
关键词
laparoscopic radical vaginal trachelectomy; cervical cancer; laparoscopy; fertility; patient eligibility;
D O I
10.1016/j.ygyno.2004.07.060
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. To determine the percentage of patients with early-stage cervical cancer who may be eligible for fertility preservation with laparoscopic radical vaginal trachelectomy (LRVT). Methods. We retrospectively reviewed the records of patients who underwent a radical hysterectomy for invasive cervical cancer at our institution from 12/85 to 8/01, before our use of LRVT at Memorial Sloan-Kettering Cancer Center. Institutional eligibility criteria for LRVT were applied. Patients greater than or equal to40 years of age were considered ineligible. Results. We identified 435 patients who had undergone radical hysterectomy for cervical cancer; 186 were age <40 at surgery and constituted our study population. Eighty-nine (48%) patients may have been eligible by our pathologic criteria. In 12 patients, LRVT may have been aborted or altered because of unexpected disease spread. Conclusion. A significant number of patients <40 with early-stage cervical cancer may be pathologically eligible for LRVT and should be counseled on this preoperatively. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:534 / 538
页数:5
相关论文
共 17 条
  • [1] BACHU A, 2001, FERTILITY AM WOMEN J, pRV20
  • [2] Pregnancy outcomes in patients after radical trachelectomy
    Bernardini, M
    Barrett, J
    Seaward, G
    Covens, A
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 189 (05) : 1378 - 1382
  • [3] Radical vaginal trachelectomy and pelvic lymphadenectomy for preservation of fertility in early cervical carcinoma
    Burnett, AF
    Roman, LD
    O'Meara, AT
    Morrow, CP
    [J]. GYNECOLOGIC ONCOLOGY, 2003, 88 (03) : 419 - 423
  • [4] Covens A, 1999, CANCER, V86, P2273, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2273::AID-CNCR15>3.0.CO
  • [5] 2-C
  • [6] Dargent D, 2000, CANCER, V88, P1877, DOI 10.1002/(SICI)1097-0142(20000415)88:8<1877::AID-CNCR17>3.3.CO
  • [7] 2-N
  • [8] Dargent D., 1994, Gynecologic Oncology, V52, P105
  • [9] Delgado G, 1978, Obstet Gynecol Surv, V33, P174, DOI 10.1097/00006254-197803000-00016
  • [10] Cancer statistics, 2004
    Jemal, A
    Tiwari, RC
    Murray, T
    Ghafoor, A
    Samuels, A
    Ward, E
    Feuer, EJ
    Thun, MJ
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2004, 54 (01) : 8 - 29